Our Technology

Liquid chromatography–mass spectrometry (LC-MS) is an analytical chemistry technique which is widely used to analyze biochemical, organic, and inorganic compounds.

Synapse Laboratory uses Sciex API 3200 QTRAP LC-MS/MS system for newborn screening.

Liquid chromatography-tandem mass spectrometry (LC–MS/MS) has greatly increased the screening possibilities by monitoring levels of amino acids and acylcarnitines in newborns. LC–MS/MS can detect more than 40 inherited disorders with a single run from just a few drops of blood.

This technology has been successfully implemented on a large scale in many jurisdictions across the world including national NBS programs and private laboratories globally.

BabySafe screens newborn babies for Inherited Metabolic Diseases (IEM). IEM are genetic diseases caused by defective proteins, which are essential for metabolic reactions.
Established since 2007, Synapse Laboratory has been providing medical testing services including DNA / RNA tests and genetic testing for newborns.

Our success resides in the dedication and commitment of our workforce.

Technology Partners

Synapse Laboratory partners with market-leaders in newborn screening and facilitate innovative new technologies to offer unique screening and diagnostic solutions.